Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF)
MEND-AF2
Mindfulness Meditation and Patient Education for Symptom Management in Individuals With Atrial Fibrillation(AF): Do They Need to Be Offered Together?
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this project is to determine whether the entire intervention (Mindfulness meditation, AF education, and weekly phone visits) that is nurse delivered to individuals with paroxysmal atrial fibrillation is more effective than a combination, single or no intervention in the reduction of overall AF symptoms, anxiety, and negative illness perception; or the improvement of quality of life (QOL) and functional status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedFirst Submitted
Initial submission to the registry
February 6, 2019
CompletedFirst Posted
Study publicly available on registry
February 8, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 2, 2024
November 1, 2024
6.7 years
February 6, 2019
November 27, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores
Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).
Baseline (Initial), Post-Intervention (6 weeks)
Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores
Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).
Baseline (Initial), 6 month
Change from Baseline Atrial Fibrillation Symptom Burden and Symptom Severity Scores
Atrial Fibrillation Burden and Symptom Severity will be calculated from the patient-completed responses on the Atrial Fibrillation Symptom Severity Scale-Symptom Burden can range from 3.25 (minimally bothersome) to 30 (continuous symptomatic episodes) and is based on event frequency (1-10), duration (1.25-10), and global episode (1-10). Symptom severity is based on symptom specific subscale with range from 0(no symptoms) to 35 (severe symptoms).
Baseline (Initial), 12 month
Change from Baseline in AF Quality of Life Score
Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.
Baseline (Initial), Post-Intervention (6 weeks)
Change from Baseline in AF Quality of Life Score
Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.
Baseline (Initial), 6 month
Change from Baseline in AF Quality of Life Score
Quality of Life will be assessed using a patient completed questionnaire, Atrial Fibrillation Effect on Quality of Life Questionnaire. The AFEQT score is a combined score of 21 items (21-100) with a higher score representing greater QOL.
Baseline (Initial), 12 month
Secondary Outcomes (3)
Change from Baseline in Anxiety
Baseline (Initial), Post-Intervention (6 weeks)
Change from Baseline in Anxiety
Baseline (Initial), 6 months
Change from Baseline in Anxiety
Baseline (Initial), 12 months
Study Arms (8)
Usual Care
NO INTERVENTIONpatient receives same care as patients not enrolled in study intervention
AF education
EXPERIMENTALParticipant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week.
Mindfulness Meditation Practice
EXPERIMENTALEach participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6.
Weekly Phone Calls
EXPERIMENTALEach week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.
AF Education and Mindfulness Meditation
EXPERIMENTALParticipant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. Each participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6.
AF Education and Weekly Phone Calls
EXPERIMENTALParticipant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.
Mindfulness Meditation and Phone Calls
EXPERIMENTALEach participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.
Meditation and Education and Phone Calls
EXPERIMENTALEach participant watches an mindfulness meditation introductory video in the initial session and then is asked to practice for 10 minutes each day using a guided audio, which includes a different topic each week. Participant receives 6 modules of AF education topics that are intended to be completed consecutively, one each week. The time duration of the guided meditations increases to 15 minutes each day during Weeks 3-6. Each week for the six-week intervention, the researcher will contact the participant by phone at an agreed upon time and will discuss any questions, issues or concerns that are voiced by the participant within 5-15 minutes.
Interventions
Guided Meditation for 10-15 minutes daily for 6 days/week for 6 weeks
6 weekly education modules on topics related to AF
Weekly phone call to discuss patient concerns or questions
Eligibility Criteria
You may qualify if:
- Individuals with Symptomatic Paroxysmal Atrial Fibrillation
- A symptomatic episode of PAF within last 6 months
- years old or greater
- Able to read and understand English
- Able to participate in weekly phone calls
- Able to attend two video visit/phone sessions that are 6 weeks apart
You may not qualify if:
- Diagnosed with low cardiac function (NYHA Class IV)
- Life expectancy of less than 6 months
- Hospitalized in prior 3 months for illness other than PAF
- Previously practiced mindfulness
- Cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Stanford Health Care
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Linda Ottoboni, PhD
Clinician and research scientist
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Medicine
Study Record Dates
First Submitted
February 6, 2019
First Posted
February 8, 2019
Study Start
May 1, 2018
Primary Completion
December 31, 2024
Study Completion
December 31, 2025
Last Updated
December 2, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share